These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8607593)

  • 1. Anti-alpha1(IV) collagen autoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome.
    Kalluri R; Petrides S; Wilson CB; Tomaszewski JE; Palevsky HI; Grippi MA; Madaio MP; Neilson EG
    Ann Intern Med; 1996 Apr; 124(7):651-3. PubMed ID: 8607593
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
    Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
    J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-type IV collagen antibodies in Goodpasture syndrome.
    Johansson C; Hellmark T; Wieslander J
    Contrib Nephrol; 1994; 107():188-93. PubMed ID: 8004967
    [No Abstract]   [Full Text] [Related]  

  • 4. Goodpasture syndrome: selective removal of anti-alpha 3 (IV) collagen autoantibodies. A potential therapeutic alternative to plasmapheresis.
    Boutaud AA; Kalluri R; Kahsai TZ; Noelken ME; Hudson BG
    Exp Nephrol; 1996; 4(4):205-12. PubMed ID: 8864724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-GBM antibodies in Goodpasture syndrome; anatomy of an epitope.
    Hellmark T; Segelmark M; Wieslander J
    Nephrol Dial Transplant; 1997 Apr; 12(4):646-8. PubMed ID: 9140985
    [No Abstract]   [Full Text] [Related]  

  • 6. Specificity of circulating and tissue-bound autoantibodies in Goodpasture syndrome.
    Kalluri R; Melendez E; Rumpf KW; Sattler K; Müller GA; Strutz F; Neilson EG
    Proc Assoc Am Physicians; 1996 Mar; 108(2):134-9. PubMed ID: 8705733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sera from patients with anti-GBM nephritis including goodpasture syndrome show heterogenous reactivity to recombinant NC1 domain of type IV collagen alpha chains.
    Dehan P; Weber M; Zhang X; Reeders ST; Foidart JM; Tryggvason K
    Nephrol Dial Transplant; 1996 Nov; 11(11):2215-22. PubMed ID: 8941581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
    Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
    Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An observed association between lung cancer and the presence of anti-Glomerular Basement Membrane antibodies.
    McGregor C; Yeo R
    Nephrology (Carlton); 2022 Mar; 27(3):290-292. PubMed ID: 34873787
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.
    Kalluri R; Danoff TM; Okada H; Neilson EG
    J Clin Invest; 1997 Nov; 100(9):2263-75. PubMed ID: 9410904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG4-restricted anti-glomerular basement membrane autoantibodies targeting quaternary epitopes of native α345(IV) collagen.
    Borza DB
    Am J Kidney Dis; 2014 Jul; 64(1):156-7. PubMed ID: 24954454
    [No Abstract]   [Full Text] [Related]  

  • 12. [Goodpasture syndrome].
    Nojima Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():403-6. PubMed ID: 15954383
    [No Abstract]   [Full Text] [Related]  

  • 13. In Reply to 'IgG4-Restricted Anti-Glomerular Basement Membrane Autoantibodies Targeting Quaternary Epitopes of Native α345(IV) Collagen'.
    Ohlsson S; Segelmark M
    Am J Kidney Dis; 2014 Jul; 64(1):157. PubMed ID: 24954458
    [No Abstract]   [Full Text] [Related]  

  • 14. [Goodpasture disease].
    Fomegné G; Dratwa M; Wens R; Mesquita M; Van der Straaten M; Vanden Haute K; Fosso C
    Rev Med Brux; 2006; 27(3):162-6. PubMed ID: 16894954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routinely used immunoassays do not detect circulating anti-GBM antibodies against native NC1 hexamer and EA epitope of the α3 chain of type IV collagen.
    Clavarino G; Gauthier A; Hellmark T; Carron PL; Giovannini D; Colliard S; Dragon-Durey MA; Segelmark M; Cesbron JY; Dumestre-Pérard C
    Eur J Immunol; 2018 Jun; 48(6):1082-1084. PubMed ID: 29644627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen.
    Wieslander J; Barr JF; Butkowski RJ; Edwards SJ; Bygren P; Heinegård D; Hudson BG
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3838-42. PubMed ID: 6328527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease.
    Ohlsson S; Herlitz H; Lundberg S; Selga D; Mölne J; Wieslander J; Segelmark M
    Am J Kidney Dis; 2014 Feb; 63(2):289-93. PubMed ID: 24189476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease.
    Hellmark T; Segelmark M; Unger C; Burkhardt H; Saus J; Wieslander J
    Kidney Int; 1999 Mar; 55(3):936-44. PubMed ID: 10027930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Goodpasture syndrome].
    Shou I; Tomino Y
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():112-9. PubMed ID: 11838103
    [No Abstract]   [Full Text] [Related]  

  • 20. The Goodpasture antigen and basement membranes: the search must go on.
    Kefalides NA
    Lab Invest; 1987 Jan; 56(1):1-3. PubMed ID: 2432351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.